Back to search

Article

Neutrophil elastase inhibitor sivelestat ameliorates gefitinib-naphthalene-induced acute pneumonitis in mice

2017-02-14

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background and objective</h4> Gefitinib, an epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI), is an effective therapeutic agent for non-small cell lung cancer with EGFR mutations. It can cause severe acute pneumonitis in some patients. We previously demonstrated that mice with naphthalene-induced airway epithelial injury developed severe gefitinib-induced pneumonitis an...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
37096aea-5221-50da-b57a-2e792d2ce9ad
DOI
10.1101/108464
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Neutrophil elastase inhibitor sivelestat ameliorates gefitinib-naphthalene-induced acute pneumonitis in miceDOI 10.1101/108464
Select a neighboring publication to make it the new centre.